Liquiritigenin is a plant-derived highly selective estrogen receptor β agonist
- 26 November 2007
- journal article
- Published by Elsevier BV in Molecular and Cellular Endocrinology
- Vol. 283 (1-2), 49-57
- https://doi.org/10.1016/j.mce.2007.11.020
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Differential Regulation of Native Estrogen Receptor-Regulatory Elements by Estradiol, Tamoxifen, and RaloxifeneMolecular Endocrinology, 2008
- DT56a (Femarelle): A natural selective estrogen receptor modulator (SERM)The Journal of Steroid Biochemistry and Molecular Biology, 2007
- Steroid hormones stimulate human prostate cancer progression and metastasisInternational Journal of Cancer, 2005
- LESSONS IN ESTROGEN BIOLOGY FROM KNOCKOUT AND TRANSGENIC ANIMALSAnnual Review of Physiology, 2005
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Estradiol and Selective Estrogen Receptor Modulators Differentially Regulate Target Genes with Estrogen Receptors α and βMolecular Biology of the Cell, 2004
- Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47DProceedings of the National Academy of Sciences, 2004
- Pilot Evaluation of Gabapentin for Treating Hot FlashesMayo Clinic Proceedings, 2002
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal WomenNew England Journal of Medicine, 1997